Inixaciclib
Product Specifications
CAS Number
2370913-42-9
Synonyms
NUV-422
Target
CDK
Applications
Cell Cycle
Molecular Formula
C26H30F2N6O
Additionnal Information
Inixaciclib (NUV-422) is a potent inhibitor of CDK2, CDK4, and CDK6. It inhibits the growth of glioma cell lines in vitro and exhibits antitumor activity in GB xenograft models, PDX models of HR+ HER2- metastatic breast cancer resistant to CDK4/6 inhibitors and prostate cancer resistant to anti-androgens.
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-0164R-BF488-TR 20 µL
BACE1 Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
Sign In for Pricing
View Details 
abx388054 96 Tests
Human Junction Adhesion Molecule Like (JAML) ELISA Kit
Sign In for Pricing
View Details MBS1404590-01 0.02 mg (E-Coli)
Recombinant Vibrio vulnificus UPF0102 protein VV0603 (VV0603)
Sign In for Pricing
View Details MBS1404590-02 0.1 mg (E-Coli)
Recombinant Vibrio vulnificus UPF0102 protein VV0603 (VV0603)
Sign In for Pricing
View Details 
MBS1404590-03 0.02 mg (Yeast)
Recombinant Vibrio vulnificus UPF0102 protein VV0603 (VV0603)
Sign In for Pricing
View Details